This week's sponsor is Premier Research. | | Beating the Odds in Early-Phase Oncology Trials Despite advances in molecular targeting, developing new cancer drugs remains a long shot. Read our white paper for insights on maximizing early-phase trial success. Premier Research. It's what we do. Best. | Today's Rundown George Church founds cryptocurrency-fueled genomics firm Johnson & Johnson opens first European JLABS incubator Madrigal says NASH drug also works in genetic cholesterol disorder [Sponsored] Can emerging technology help biopharma improve the returns on R&D? UCB spins out neuro startup with €17M from Novo, Johnson & Johnson Sinclair Research poaches Covance, Lilly veteran Wakefield Algorithm identifies diabetics in Apple Watch heart data Featured Story | Thursday, February 8, 2018 George Church is betting blockchain technology and a cryptocurrency will smash perceived barriers to widespread genome sequencing. The prolific startup creator has cofounded Nebula Genomics in a belief the red-hot technologies will drive down the cost of sequencing while allaying privacy fears. |
|
| This week's sponsor is Dell EMC. | | [Webinar] Is Your Life Science Data "F-A-I-R"? Tuesday, February 13 | 2pm ET / 11am PT Is Your Life Science Data "F-A-I-R"? Join DataFrameworks & Dell EMC in this webinar to discover a new approach to create scientific data that is findable, accessible, interoperable, and reusable. Register now! | Top Stories Thursday, February 8, 2018 Johnson & Johnson has opened its first JLABS incubator in Europe. The 30-startup hub will supersede the JLINX incubator J&J helped to set up at its R&D site in Beerse, Belgium. Thursday, February 8, 2018 Madrigal Pharma is celebrating after its lead drug, MGL-3196, hit the mark in a phase 2 trial in the second of its two target indications: heterozygous familial hypercholesterolemia. Monday, February 5, 2018 While biopharma companies are investing more than ever to develop innovative therapies, returns are not keeping pace. How can emerging technologies help improve productivity? Learn more from Deloitte’s annual ROI analysis. Thursday, February 8, 2018 Syndesi Therapeutics begins life with a $20.9 million infusion, to carry a SV2A modulator through early proof of concept. Thursday, February 8, 2018 Preclinical contract research organization Sinclair Research has carved out a new role for G. Alex Wakefield as he becomes its vice president of research and operations. Thursday, February 8, 2018 Researchers have developed an algorithm that can identify people previously diagnosed with diabetes in Apple Watch heart data. The learning algorithm provides a strong model for identifying people with diabetes but is yet to prove itself against the tougher task of spotting undiagnosed patients without also racking up false positives. This week's sponsor is IQVIA. | | Discover a new path to your success via Human Data Science. IMS Health and Quintiles are now IQVIA™ – created to advance your pursuits of human science by unleashing the power of data science and human ingenuity. Join the journey today. Learn More. | Resources Sponsored by: RBC Wealth Management Guiding corporate executives through regulatory complexities, while delivering an array of sophisticated investment options. Learn more. Presented by: Patheon Download Patheon’s whitepaper to discover two main areas where a drug developer can face significant obstacles during biologics development and how by evaluating these capabilities, it can answer the critical question of whether its in-house strategy is ready for these uncertainties. Presented by: SDC and Stiris Research What do you do when timelines are missed, data is dirty, and everyone is pointing fingers? Watch this webinar to learn how to prevent, identify, and implement a successful clinical trial rescue. Sponsored by: Veeva Systems Expanding into new markets places a spotlight on inefficient processes. Sponsored by: Veeva Systems Regulatory leaders share challenges and best practices from a lack of standardization, manual processes, and fragmented systems. Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Presented by: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented by: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented by: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented by: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented by: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored by: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel BioBasics: Biotech for the Non-Scientist March 29-30, 2018 | Boston, MA Healthcare Internet of Things February 13-14, 2018 | Moscone South Convention Center | San Francisco, CA PEGS: The Essential Protein Engineering Summit April 30-May 4 | Boston, MA |